| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |